Get the Stockscreener App
1.21
1.25%
+0.01
Personalis Inc stock is currently priced at $1.21, with a 24-hour trading volume of 211.16K.
It has seen a +1.25% increased in the last 24 hours and a -25.46% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $1.24 pivot point. If it approaches the $1.15 support level, significant changes may occur.
Personalis Inc Stock (PSNL) Financials Data
Personalis Inc (PSNL) Revenue 2024
PSNL reported a revenue (TTM) of $73.48 million for the quarter ending December 31, 2023, a +12.97% rise year-over-year.
Personalis Inc (PSNL) Net Income 2024
PSNL net income (TTM) was -$108.30 million for the quarter ending December 31, 2023, a +4.43% increase year-over-year.
Personalis Inc (PSNL) Cash Flow 2024
PSNL recorded a free cash flow (TTM) of -$67.17 million for the quarter ending December 31, 2023, a +44.09% increase year-over-year.
Personalis Inc (PSNL) Earnings per Share 2024
PSNL earnings per share (TTM) was -$2.25 for the quarter ending December 31, 2023, a +9.27% growth year-over-year.
Personalis Inc Stock (PSNL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Tachibana Aaron | CFO AND COO |
Jan 29 '24 |
Sale |
1.37 |
716 |
981 |
184,521 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jan 29 '24 |
Sale |
1.37 |
526 |
721 |
128,870 |
| Tachibana Aaron | CFO and COO |
Dec 15 '23 |
Sale |
1.47 |
6,747 |
9,918 |
185,237 |
| Chen Richard | Chief Medical Officer and EVP |
Dec 15 '23 |
Sale |
1.47 |
4,708 |
6,921 |
129,396 |
| Moore Stephen Michael | General Counsel |
Dec 15 '23 |
Sale |
1.47 |
1,476 |
2,170 |
76,920 |
| Moore Stephen Michael | General Counsel |
Nov 16 '23 |
Sale |
1.04 |
1,722 |
1,791 |
78,396 |
| Tachibana Aaron | CFO and COO |
Nov 16 '23 |
Sale |
1.04 |
1,344 |
1,398 |
191,984 |
| Chen Richard | Chief Medical Officer and EVP |
Nov 16 '23 |
Sale |
1.04 |
940 |
978 |
124,104 |
| Hall Christopher M | President and CEO |
Nov 01 '23 |
Sale |
0.93 |
20,459 |
19,027 |
204,541 |
| Tachibana Aaron | CFO and COO |
Jul 31 '23 |
Sale |
2.26 |
662 |
1,496 |
193,328 |
Personalis Inc Stock (PSNL) Latest News
Cathie Wood's Ark Laps Up $3.3M Worth Of Tesla As Stock Falls For 3rd Straight Session, Sheds Shares Of This Sports Betting Company
Benzinga
Cathie Wood's Ark Laps Up $3.3M Worth Of Tesla As Stock Falls For 3rd Straight Session, Sheds Shares Of This Sports Betting Company
Benzinga
Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor
Benzinga
Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
Benzinga
Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery
Benzinga
Cathie Wood's Ark Invest Isn't Done Selling Shares Of Jack Dorsey-Led Block Yet — Sheds $7.5M Worth of Stock As Bitcoin Price Drops
Benzinga
About Personalis Inc
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves approximately 45 biopharmaceutical customers, including a range of pharmaceutical companies. The company was founded in 2011 and is headquartered in Menlo Park, California.
COMPANY PROFILE
NamePersonalis Inc
SectorHealthcare (1198)
IndustryDiagnostics & Research (66)
Web
Phone650-752-1300
Employee147
Twitter
@PersonalisInc
SEC filings
Latest SEC Filings
Next earning date2024-05-01
Address1330 O'Brien Drive, Menlo Park, CA, United States (94025)
0.57%
1.85%
Cap:
|
Volume (24h):